Literature DB >> 31817101

Cancer-Derived Extracellular Vesicle-Associated MicroRNAs in Intercellular Communication: One Cell's Trash Is Another Cell's Treasure.

Joseph Mills1, Marina Capece1, Emanuele Cocucci2, Anna Tessari1, Dario Palmieri1.   

Abstract

Several non-protein-coding genomic regions, previously marked as "junk DNA", have been reported to be transcriptionally active, giving rise to non-coding RNA species implicated in fundamental biological and pathological processes. In particular, microRNAs (miRNAs), a class of small non-coding RNAs mediating post-transcriptional gene silencing, are causally involved in several human diseases, including various cancer types. Extracellular vesicles (EVs) are membranous structures physiologically released by most cell types. Initially, they were considered a "waste-removal" mechanism, through which cells could dispose unnecessary material and organelles. It is now widely demonstrated that EVs also play a critical role in intercellular communication, mediating the horizontal transfer of lipids, proteins, and genetic material. A paradigm shift in the biology of miRNAs was represented by the discovery that EVs, especially from cancer cells, contain miRs. EV-associated miRs act as autocrine, paracrine and endocrine factors, participating in cancer pathogenesis by modulating intercellular communication. Noteworthy, these formerly neglected molecules are now considered the next generation of cancer "theranostic" tools, with strong clinical relevance. In this review, we aim to summarize the most recent findings regarding EV-associated miRs in cancer pathogenesis and in the development of novel anti-neoplastic diagnostic and therapeutic approaches.

Entities:  

Keywords:  EVs; exosomes; extracellular vesicles; miRs; microRNAs; microvesicles; tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 31817101      PMCID: PMC6940802          DOI: 10.3390/ijms20246109

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  203 in total

1.  The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting.

Authors:  Laura Santangelo; Giorgio Giurato; Carla Cicchini; Claudia Montaldo; Carmine Mancone; Roberta Tarallo; Cecilia Battistelli; Tonino Alonzi; Alessandro Weisz; Marco Tripodi
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

2.  Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.

Authors:  Tomohiro Umezu; Hiroko Tadokoro; Kenko Azuma; Seiichiro Yoshizawa; Kazuma Ohyashiki; Junko H Ohyashiki
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

3.  Cancer biomarker discovery and validation.

Authors:  Nicolas Goossens; Shigeki Nakagawa; Xiaochen Sun; Yujin Hoshida
Journal:  Transl Cancer Res       Date:  2015-06       Impact factor: 1.241

4.  Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.

Authors:  June-Chul Lee; Kyung-Mi Lee; Dong-Wan Kim; Dae Seog Heo
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

5.  Diverse Long RNAs Are Differentially Sorted into Extracellular Vesicles Secreted by Colorectal Cancer Cells.

Authors:  Scott A Hinger; Diana J Cha; Jeffrey L Franklin; James N Higginbotham; Yongchao Dou; Jie Ping; Lihua Shu; Nripesh Prasad; Shawn Levy; Bing Zhang; Qi Liu; Alissa M Weaver; Robert J Coffey; James G Patton
Journal:  Cell Rep       Date:  2018-10-16       Impact factor: 9.423

6.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

7.  Vesicle fusion and formation at the surface of pinocytic vacuoles in macrophages.

Authors:  J G Hirsch; M E Fedorko; Z A Cohn
Journal:  J Cell Biol       Date:  1968-09       Impact factor: 10.539

8.  Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.

Authors:  Liya Zhu; Senthilkumar Kalimuthu; Prakash Gangadaran; Ji Min Oh; Ho Won Lee; Se Hwan Baek; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Theranostics       Date:  2017-07-07       Impact factor: 11.556

9.  Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles.

Authors:  Mohashin Pathan; Pamali Fonseka; Sai V Chitti; Taeyoung Kang; Rahul Sanwlani; Jan Van Deun; An Hendrix; Suresh Mathivanan
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p.

Authors:  Mosavar Farahani; Carlos Rubbi; Luning Liu; Joseph R Slupsky; Nagesh Kalakonda
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more
  16 in total

1.  Quantitative and Multiplex Detection of Extracellular Vesicle-Derived MicroRNA via Rolling Circle Amplification within Encoded Hydrogel Microparticles.

Authors:  Dana Al Sulaiman; Nidhi Juthani; Patrick S Doyle
Journal:  Adv Healthc Mater       Date:  2022-01-22       Impact factor: 11.092

2.  Mycosis fungoides-derived exosomes promote cell motility and are enriched with microRNA-155 and microRNA-1246, and their plasma-cell-free expression may serve as a potential biomarker for disease burden.

Authors:  L Moyal; C Arkin; B Gorovitz-Haris; C Querfeld; S Rosen; J Knaneh; I Amitay-Laish; H Prag-Naveh; J Jacob-Hirsch; E Hodak
Journal:  Br J Dermatol       Date:  2021-08-13       Impact factor: 11.113

Review 3.  Exosome: A New Player in Translational Nanomedicine.

Authors:  Houssam Aheget; María Tristán-Manzano; Loubna Mazini; Marina Cortijo-Gutierrez; Pablo Galindo-Moreno; Concha Herrera; Francisco Martin; Juan Antonio Marchal; Karim Benabdellah
Journal:  J Clin Med       Date:  2020-07-26       Impact factor: 4.241

Review 4.  Mesenchymal Stromal Cell-Derived Extracellular Vesicles - Silver Linings for Cartilage Regeneration?

Authors:  Andrea De Luna; Alexander Otahal; Stefan Nehrer
Journal:  Front Cell Dev Biol       Date:  2020-12-10

5.  Editorial to the Special Issue "MicroRNA Dysregulation in Tumor Occurrence, Progression and Response to Therapy".

Authors:  Marilena V Iorio
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

Review 6.  Cell-to-Cell Communication by Host-Released Extracellular Vesicles in the Gut: Implications in Health and Disease.

Authors:  Natalia Diaz-Garrido; Cecilia Cordero; Yenifer Olivo-Martinez; Josefa Badia; Laura Baldomà
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

Review 7.  Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma.

Authors:  Lisa Linck-Paulus; Claus Hellerbrand; Anja K Bosserhoff; Peter Dietrich
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

8.  Analysis of RNA yield in extracellular vesicles isolated by membrane affinity column and differential ultracentrifugation.

Authors:  Gilberto Gutiérrez García; Gabriela Galicia García; Jessica Zalapa Soto; Andrea Izquierdo Medina; Mariana Rotzinger-Rodríguez; Gustavo Antonio Casas Aguilar; Cynthia Paola López Pacheco; Álvaro Aguayo; Maria Montserrat Aguilar-Hernandez
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

Review 9.  Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.

Authors:  Xuan T T Dang; Jayasinghe Migara Kavishka; Daniel Xin Zhang; Marco Pirisinu; Minh T N Le
Journal:  Cells       Date:  2020-09-29       Impact factor: 6.600

10.  Analytical and clinical validation of pairwise microRNA expression analysis to identify medullary thyroid cancer in thyroid fine-needle aspiration samples.

Authors:  Andrea M Ciarletto; Christina Narick; Carl D Malchoff; Nicole A Massoll; Emmanuel Labourier; Keith Haugh; Alidad Mireskandari; Sydney D Finkelstein; Gyanendra Kumar
Journal:  Cancer Cytopathol       Date:  2020-10-05       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.